Eficácia do sistema liberador de levonorgestrel no tratamento da dor pélvica crônica associada a endometriose / Efficacy of levonorgestrel-releasing system in the treatment of chronic pelvic pain associated with endometriosis
This review evaluated the efficacy of a levonorgestrel-releasing intrauterine system for treating chronic pelvic pain associated with endometriosis, concluding it is effective with fewer adverse effects.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (15)
- A levonorgestrel-releasing intrauterine system for the treatment of dysmenorrhea associated with endometriosis: a pilot study via openalex
- Comparison of a levonorgestrel-releasing intrauterine device versus expectant management after conservative surgery for symptomatic endometriosis: a pilot study via openalex
- Conservative treatment of rectosigmoid endometriosis: A prospective study via openalex
- Levonorgestrel‐releasing intrauterine system (Mirena <sup>®</sup> ) and Depot medroxyprogesterone acetate (Depoprovera) as long‐term maintenance therapy for patients with moderate and severe endometriosis: A randomised controlled trial via openalex
- Postoperative administration of dienogest plus estradiol valerate versus levonorgestrel‐releasing intrauterine device for prevention of pain relapse and disease recurrence in endometriosis patients via openalex
- Postoperative Levonorgestrel-Releasing Intrauterine System for Pelvic Endometriosis-Related Pain via openalex
- The efficacy, side-effects and continuation rates in women with symptomatic endometriosis undergoing treatment with an intra-uterine administered progestogen (levonorgestrel): a 3 year follow-up via openalex
- The evaluation of the effectiveness of an intrauterine-administered progestogen (levonorgestrel) in the symptomatic treatment of endometriosis and in the staging of the disease via openalex
- The levonorgestrel-releasing intrauterine system and endometriosis staging via openalex
- The levonorgestrel‐releasing intrauterine system is associated with a reduction in dysmenorrhoea and dyspareunia, a decrease in <scp>CA</scp> 125 levels, and an increase in quality of life in women with suspected endometriosis via openalex
- Use of a levonorgestrel-releasing intrauterine device in the treatment of rectovaginal endometriosis via openalex
- W2131027406 via openalex
- W2123134517 via openalex
- W2899183806 via openalex
- W2053998452 via openalex
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00